Caij GLP-1 Wave, Novo Nordisk tso tawm $ 560M txhawm rau txhawb kev tsim tshuaj hauv Suav teb

Tuam Tshoj kev nqis peev cog lus los ntawm kev nthuav dav thoob ntiaj teb rau Novo Nordisk. (Novo Nordisk)

Xyoo no yog Novo Nordisk's 30th hnub tseem ceeb hauv Suav teb, thiab nws tseem tuaj yeem yog xyoo uas lub tuam txhab kev txhaj tshuaj liab-kub poob Wegovy (semaglutide) tau txais kev pom zoo nyob rau hauv cov neeg Esxias sab hnub tuaj uas tau nce zuj zus nrog cov kab mob xws li kev rog thiab ntshav qab zib.

Tam sim no, Novo tau rov qab los rau nws cov hauv paus hniav nrog kev nthuav dav ntawm cov tuam txhab tshuaj suav tshuaj suav teb uas nws tau qhib hauv Tianjin, Tuam Tshoj, rov qab rau xyoo 1994.

Novo Nordisk tab tom nqis peev kwv yees li 4 billion yuan (kwv yees li $ 556 lab) hauv nws qhov chaw Tianjin uas yog ib feem ntawm kev npaj ua kom tsis muaj menyuam, lub tuam txhab tau hais hauv kev tshaj tawm lus Suav hnub Tuesday. Novo twb tau tawg hauv qhov project, uas nws xav tias yuav ua tiav hauv 2027.

Cov nroj tsuag tsim tawm yuav txhawb nqa lub peev xwm tsim khoom hauv Suav teb kom "ua tau raws li cov kev xav tau ntawm Suav cov neeg mob rau cov tshuaj tshiab," Novo tau piav qhia hauv nws qhov kev tso tawm, yam tsis muaj npe cov tshuaj tshwj xeeb uas nws npaj yuav ua ntawm lub Hoobkas ua kua zaub.

Novo muaj ntau yam laj thawj los txhawb nws txoj kev tsim khoom hauv Suav teb. Tus kws tsim tshuaj lub cev rog rog Wegovy xav tias yuav tau txais kev pom zoo nyob ntawd tom qab xyoo no, Reuters tsis ntev los no tau tshaj tawm.

Novo's Tuam Tshoj tshaj tawm yuav pib tsom mus rau cov neeg mob them nyiaj tawm ntawm hnab tshos rau Wegovy, xov xwm tshaj tawm, hais txog Novo tus thawj coj ntawm kev lag luam hauv Suav teb, Christine Zhou Xiaping.

Hais txog

Novo's rog superstar Wegovy yeej FDA nod los txiav cardio txaus ntshai nyob rau hauv cov ntawv tseem ceeb nthuav dav

Tus kws tsim tshuaj Danish thawj zaug teeb tsa lub khw hauv Tianjin rov qab rau xyoo 1994. Tsis ntev los no, thaum muaj kev xav tau zoo rau lub tuam txhab cov ntshav qab zib thiab cov khoom poob, Novo thaum ntxov 2023 tau nqis peev ib qho kev sib cais ntawm 1.18 billion yuan (kwv yees $ 164 lab) hauv cov nroj tsuag kom nthuav dav. nws cov khoom tiav rhiav thiab qhia ib tug pre-filled txhaj cwj mem ntau lawm kab.

Lub tuam txhab txoj haujlwm tshiab tshaj plaws tau teeb tsa los siv cov thev naus laus zis thev naus laus zis thev naus laus zis los txhim kho cov txheej txheem tsim cov tshuaj tsis muaj menyuam, Novo tau piav qhia hauv nws qhov kev tso tawm.

Ib cag ntawm nws cov chaw tsim khoom suav hauv Tianjin, Novo Nordisk hais tias nws tseem ua haujlwm R & D hub hauv Beijing.

Novo Nordisk kev nqis peev hauv Suav teb yog ib feem ntawm lub tuam txhab kev nruj kev lag luam thoob ntiaj teb kev nthuav dav. Nyob rau nruab nrab Lub Kaum Ib Hlis, lub tuam txhab tau hais tias nws yuav siv li ntawm $ 6 nphom los nthuav lub tsev kawm ntawv tsim khoom hauv Denmark.

Tom qab tib lub hlis ntawd, Novo tau ua nthwv dej ib zaug ntxiv thaum nws npaj ib qho $ 2.3 nphom nthuav dav hauv Fabkis.

Hais txog

JPM24: Nyob rau hauv booming rog rog, Novo Nordisk yog 'cia li mus,' CEO hais

Tom qab ntawd, ua ntej lub xyoo no, Novo Holdings ua rau tag nrho cov ntawv cog lus tsim kev lag luam thaum nws tsiv mus yuav Catalent rau $ 16.5 billion. Raws li ib feem ntawm txoj kev npaj, Novo Nordisk tau teem caij yuav Catalent sau cov nroj tsuag tiav hauv Ltalis, Belgium thiab Asmeskas rau $ 11 nphom ua ntej.

Nyob rau hauv kev loj hlob spree, Novo Nordisk tau catapulted los ua Tebchaws Europe cov tuam txhab saum toj kawg nkaus los ntawm kev ua lag luam tus nqi, qhia tias GLP-1 npau taws ntawm tus kws tsim tshuaj nyob ntawm no.

 

 

"Cov kab lus no yog siv rau kev sib koom ua ke. Yog tias muaj kev ua txhaum cai, thov hu rau peb, thiab peb yuav tshem tawm nws."